These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27465878)

  • 1. How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection?
    Rodger AJ; Sabin CA
    Curr Opin HIV AIDS; 2016 Sep; 11(5):487-491. PubMed ID: 27465878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question.
    Eholié SP; Badje A; Kouame GM; N'takpe JB; Moh R; Danel C; Anglaret X
    AIDS Res Ther; 2016; 13():27. PubMed ID: 27462361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Geffen N; Aagaard P; Corbelli GM; Meulbroek M; Peavy D; Rappoport C; Schwarze S; Collins S;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):10-3. PubMed ID: 25711318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of antiretroviral therapy based on the 2015 WHO guidelines.
    Kuznik A; Iliyasu G; Habib AG; Musa BM; Kambugu A; Lamorde M
    AIDS; 2016 Nov; 30(18):2865-2873. PubMed ID: 27662547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
    Bigna JJ; Plottel CS; Koulla-Shiro S
    Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to start antiretroviral therapy: the need for an evidence base during early HIV infection.
    Lundgren JD; Babiker AG; Gordin FM; Borges ÁH; Neaton JD
    BMC Med; 2013 Jun; 11():148. PubMed ID: 23767777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.
    Schomaker M; Davies MA; Malateste K; Renner L; Sawry S; N'Gbeche S; Technau KG; Eboua F; Tanser F; Sygnaté-Sy H; Phiri S; Amorissani-Folquet M; Cox V; Koueta F; Chimbete C; Lawson-Evi A; Giddy J; Amani-Bosse C; Wood R; Egger M; Leroy V;
    Epidemiology; 2016 Mar; 27(2):237-46. PubMed ID: 26479876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections.
    Lawn SD; Török ME; Wood R
    Curr Opin Infect Dis; 2011 Feb; 24(1):34-42. PubMed ID: 21150593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Initiation of Antiretroviral Therapy after HIV Diagnosis.
    García-Deltoro M
    AIDS Rev; 2019; 21(2):55-64. PubMed ID: 31332395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
    Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
    Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
    Lodi S; Sharma S; Lundgren JD; Phillips AN; Cole SR; Logan R; Agan BK; Babiker A; Klinker H; Chu H; Law M; Neaton JD; Hernán MA;
    AIDS; 2016 Nov; 30(17):2659-2663. PubMed ID: 27782964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection.
    Lifson AR; Grund B; Gardner EM; Kaplan R; Denning E; Engen N; Carey CL; Chen F; Dao S; Florence E; Sanz J; Emery S;
    AIDS; 2017 Apr; 31(7):953-963. PubMed ID: 28121710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy: when to start.
    Sellers CJ; Wohl DA
    Infect Dis Clin North Am; 2014 Sep; 28(3):403-20. PubMed ID: 25151563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data.
    HIV Paediatric Prognostic Markers Collaborative Study
    Lancet; 2005 Nov; 366(9500):1868-74. PubMed ID: 16310553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to start antiretroviral therapy?
    Wilkin TJ; Gulick RM
    Clin Infect Dis; 2008 Dec; 47(12):1580-6. PubMed ID: 18990069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.